BMP-2 inhibits proliferation of human aortic smooth muscle cells via p21Cip1/Waf1

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 5 47-5, 2003, Pages

  Wong, Gail A ^a,c,d   Tang, Vincent ^a,c   El Sabeawy, Faten ^a   Weiss, Robert H ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antisense; Bone morphogenetic protein 2; Vascular smooth muscle cell

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; PROTEIN P21;

AORTA MEDIA; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; MINERALIZATION; MITOGENICITY; OSTEOBLAST; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STEM CELL; VASCULAR SMOOTH MUSCLE;

EID: 0037403370     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00385.2002     Document Type: Article

References (31)

1. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K, and Mizutani S. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J 18: 1223-1234, 1999.
2. Banskota NK, Taub R, Zellner K, and King GL. Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. Mol Endocrinol 3: 1183-1190, 1989.
3. Bartek J and Lukas J. Pathways governing G1/S transition and their response to DNA damage. FEBS Lett 490: 117-122, 2001.
4. Chang MW, Barr E, Lu MM, Barton K, and Leiden JM. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21, inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest 96: 2260-2268, 1995.
5. Dorai H, Vukicevic S, and Sampath TK. Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro. J Cell Physiol 184: 37-45, 2000.
6. Franzen A and Heldin NE. BMP-7-induced cell cycle arrest of anaplastic thyroid carcinoma cells via p21(CIP1) and p27(KIP1). Biochem Biophys Res Commun 285: 773-781, 2001.
7. Ghosh-Choudhury N, Ghosh-Choudhury G, Celeste A, Ghosh PM, Moyer M, Abboud SL, and Kreisberg J. Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells. Biochim Biophys Acta 1497: 186-196, 2000.
8. Harbour JW and Dean DC. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 14: 2393-2409, 2000.
9. Hayashi S, Morishita R, Matsushita H, Nakagami H, Taniyama Y, Nakamura T, Aoki M, Yamamoto K, Higaki J, and Ogihara T. Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21. Hypertension 35: 237-243, 2000.
10. Hupfeld CJ and Weiss RH. TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27. Am J Physiol Endocrinol Metab 281: E207-E216, 2001.
11. Ishida A, Sasaguri T, Kosaka C, Nojima H, and Ogata J. Induction of the cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells. J Biol Chem 272: 10050-10057, 1997.
12. Kawamura C, Kizaki M, Yamato K, Uchida H, Fukuchi Y, Hattori Y, Koseki T, Nishihara T, and Ikeda Y. Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3. Blood 96: 2005-2011, 2000.
13. Kim GY, Mercer SE, Ewton DZ, Yan Z, Jin K, and Friedman E. The stress-activated kinases p38alpha and Jnk1 stabilize p21cip1 by phosphorylation. J Biol Chem: 29792-29802, 2002.
14. Kimura N, Matsuo R, Shibuya H, Nakashima K, and Taga T. BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J Biol Chem 275: 17647-17652, 2000.
15. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, and Harlow E. New functional activities for the p21 family of CDK inhibitors. Genes Dev 11: 847-862, 1997.
16. Li Y, Dowbenko D, and Lasky LA. AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem 277: 11352-11361, 2002.
17. Marra DE, Simoncini T, and Liao JK. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1). Circulation 102: 2124-2130, 2000.
18. Moses HL, Yang EY, and Pietenpol JA. TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63: 245-247, 1990.
19. Nakaoka T, Gonda K, Ogita T, Otawara-Hamamoto Y, Okabe F, Kira Y, Harii K, Miyazono K, Takuwa Y, and Fujita T. Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. J Clin Invest 100: 2824-2832, 1997.
20. Nakashima K, Yanagisawa M, Arakawa H, and Taga T. Astrocyte differentiation mediated by LIF in cooperation with BMP2. FEBS Lett 457: 43-46, 1999.
21. Ogasawara TKM, Miura T, Susami T, Takato T, Nakamura K, and Okayama H. Osteoblast diffentiation by BMP2 is mediated by downregulation of CDK6 (Abstract). J Bone Miner Res 16: S203, 2001.
22. Reddi AH. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 16: 247-252, 1998.
23. Riley EH, Lane JM, Urist MR, Lyons KM, and Lieberman JR. Bone morphogenetic protein-2: biology and applications. Clin Orthop: 39-46, 1996.
24. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 138: S419-S420, 1999.
25. Ross R, Masuda J, Raines EW, Gown AM, Katsuda S, Sasahara M, Malden LT, Masuko H, and Sato H. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 248: 1009-1012, 1990.
26. Sandirasegarane L and Kester M. Enhanced stimulation of Akt-3/protein kinase B-gamma in human aortic smooth muscle cells. Biochem Biophys Res Commun 283: 158-163, 2001.
27. Sporn MB and Roberts AB. Transforming growth factor-beta: recent progress and new challenges. J Cell Biol 119: 1017-1021, 1992.
28. Takuwa Y, Ohse C, Wang EA, Wozney JM, and Yamashita K. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun 174: 96-101, 1991.
29. Tintut Y, Parhami F, Bostrom K, Jackson SM, and Demer LL. cAMP stimulates osteoblast-like differentiation of calcifying vascular cells. Potential signaling pathway for vascular calcification. J Biol Chem 273: 7547-7553, 1998.
30. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, LaPan P, Luxenberg DP, McQuaid D, Moutsatsos IK, Nove J, and Wozney JM. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87: 2220-2224, 1990.
31. Weiss RH, Joo A, and Randour C. p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem 275: 10285-10290, 2000.